Assertion: advanced melanoma | /r/CapableOf | progress after anti-ctla-4 treatment
Facets:
Source sentences:
text: Nivolumab versus chemotherapy in patients with advanced melanoma who progressed after anti-CTLA-4 treatment (CheckMate 037): a randomised, controlled, open-label, phase 3 trial.